Линчев синдром (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Линчев синдром" in Serbian language version.

refsWebsite

Global rank Serbian rank

13nih.gov

4^th place

8^th place

12doi.org

2^nd place

4^th place

6cdc.gov

218^th place

138^th place

2web.archive.org

1^st place

2semanticscholar.org

11^th place

23^rd place

2dynamed.com

low place

1mypathologyreport.ca

low place

1archive.org

6^th place

5^th place

1archivesofpathology.org

low place

1archive.today

14^th place

22^nd place

1jco.org

low place

archive.org

Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, et al. (јануар 2001). „Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds”. American Journal of Human Genetics. 68 (1): 118—127. PMC 1234904 . PMID 11112663. doi:10.1086/316942.

archive.today

Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, et al. (децембар 2004). „Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic”. Journal of Clinical Oncology. 22 (24): 4934—43. PMID 15611508. doi:10.1200/JCO.2004.11.084. Архивирано из оригинала 2013-04-15. г.

archivesofpathology.org

Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (новембар 2005). „Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability”. Archives of Pathology & Laboratory Medicine. 129 (11): 1390—7. PMID 16253017. doi:10.5858/2005-129-1390-POTRBG.

cdc.gov

„Lynch Syndrome | CDC”. www.cdc.gov (на језику: енглески). 2022-03-09. Приступљено 2023-01-21.
„The Basics of Hereditary Colorectal (Colon) Cancer | CDC”. www.cdc.gov (на језику: енглески). 2022-03-09. Приступљено 2023-01-21.
„Immunohistochemistry screening (IHC) | CDC”. www.cdc.gov (на језику: енглески). 2022-10-13. Приступљено 2023-01-21.
„Microsatellite Instability (MSI) screening | CDC”. www.cdc.gov (на језику: енглески). 2020-04-01. Приступљено 2023-01-21.
„Genetic Testing for Lynch Syndrome | CDC”. www.cdc.gov (на језику: енглески). 2019-06-27. Приступљено 2023-01-21.
„Medical Options | CDC”. www.cdc.gov (на језику: енглески). 2022-03-09. Приступљено 2023-01-21.

doi.org

Kastrinos, Fay; Mukherjee, B.; Tayob, N.; Wang, F.; Sparr, J.; Raymond, V. M.; Bandipalliam, P.; Stoffel, E. M.; Gruber, S. B.; Syngal, S. (2009). „Risk of Pancreatic Cancer in Families with Lynch Syndrome”. JAMA. 302 (16): 1790—1795. PMC 4091624 . PMID 19861671. doi:10.1001/jama.2009.1529. .
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (фебруар 1966). „Hereditary factors in cancer. Study of two large midwestern kindreds”. Archives of Internal Medicine. 117 (2): 206—12. PMID 5901552. doi:10.1001/archinte.117.2.206.
Bellizzi AM, Frankel WL (новембар 2009). „Colorectal cancer due to deficiency in DNA mismatch repair function: a review”. Advances in Anatomic Pathology. 16 (6): 405—17. PMID 19851131. S2CID 25600795. doi:10.1097/PAP.0b013e3181bb6bdc.
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. (април 2005). „Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X”. JAMA. 293 (16): 1979—85. PMC 2933042 . PMID 15855431. doi:10.1001/jama.293.16.1979.
Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, et al. (јануар 2001). „Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds”. American Journal of Human Genetics. 68 (1): 118—127. PMC 1234904 . PMID 11112663. doi:10.1086/316942.
Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (новембар 2005). „Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability”. Archives of Pathology & Laboratory Medicine. 129 (11): 1390—7. PMID 16253017. doi:10.5858/2005-129-1390-POTRBG.
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, et al. (фебруар 2004). „Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability”. Journal of the National Cancer Institute. 96 (4): 261—8. PMC 2933058 . PMID 14970275. doi:10.1093/jnci/djh034.
Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, et al. (децембар 2004). „Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic”. Journal of Clinical Oncology. 22 (24): 4934—43. PMID 15611508. doi:10.1200/JCO.2004.11.084. Архивирано из оригинала 2013-04-15. г.
Stjepanovic, N.; Moreira, L.; Carneiro, F.; Balaguer, F.; Cervantes, A.; Balmaña, J.; Martinelli, E.; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2019). „Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†”. Annals of Oncology. 30 (10): 1558—1571. PMID 31378807. doi:10.1093/annonc/mdz233.
Boland, C. Richard; Koi, Minoru; Chang, Dong K.; Carethers, John M. (2008). „The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: From bench to bedside”. Familial Cancer. 7 (1): 41—52. PMC 2847875 . PMID 17636426. doi:10.1007/s10689-007-9145-9. .
Le, Dung T.; et al. (2015). „PD-1 Blockade in Tumors with Mismatch-Repair Deficiency”. New England Journal of Medicine. 372 (26): 2509—2520. PMC 4481136 . PMID 26028255. doi:10.1056/NEJMoa1500596. .
André, Thierry; Shiu, Kai-Keen; Kim, Tae Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis; Smith, Denis; Garcia-Carbonero, Rocio; Benavides, Manuel; Gibbs, Peter; de la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T.; Yoshino, Takayuki; Van Cutsem, Eric; Yang, Ping; Farooqui, Mohammed Z.H.; Marinello, Patricia; Diaz, Luis A.; KEYNOTE-177 Investigators (2020). „Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer”. New England Journal of Medicine. 383 (23): 2207—2218. PMID 33264544. S2CID 227259533. doi:10.1056/NEJMoa2017699.

dynamed.com

„Lynch Syndrome”. DynaMed. 22. 2. 2019. Приступљено 18. 11. 2019.
„Lynch Syndrome, General Information”. www.dynamed.com. Приступљено 2023-01-22.

jco.org

Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, et al. (децембар 2004). „Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic”. Journal of Clinical Oncology. 22 (24): 4934—43. PMID 15611508. doi:10.1200/JCO.2004.11.084. Архивирано из оригинала 2013-04-15. г.

mypathologyreport.ca

„Протеини за поправку неусклађености (ММР) - Патолошки речник - МиПатхологиРепорт.ца”. MyPathologyReport.ca (на језику: српски). Архивирано из оригинала 21. 01. 2023. г. Приступљено 2023-01-21.

nih.gov

ncbi.nlm.nih.gov

Kastrinos, Fay; Mukherjee, B.; Tayob, N.; Wang, F.; Sparr, J.; Raymond, V. M.; Bandipalliam, P.; Stoffel, E. M.; Gruber, S. B.; Syngal, S. (2009). „Risk of Pancreatic Cancer in Families with Lynch Syndrome”. JAMA. 302 (16): 1790—1795. PMC 4091624 . PMID 19861671. doi:10.1001/jama.2009.1529. .
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (фебруар 1966). „Hereditary factors in cancer. Study of two large midwestern kindreds”. Archives of Internal Medicine. 117 (2): 206—12. PMID 5901552. doi:10.1001/archinte.117.2.206.
Bellizzi AM, Frankel WL (новембар 2009). „Colorectal cancer due to deficiency in DNA mismatch repair function: a review”. Advances in Anatomic Pathology. 16 (6): 405—17. PMID 19851131. S2CID 25600795. doi:10.1097/PAP.0b013e3181bb6bdc.
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. (април 2005). „Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X”. JAMA. 293 (16): 1979—85. PMC 2933042 . PMID 15855431. doi:10.1001/jama.293.16.1979.
Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, et al. (јануар 2001). „Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds”. American Journal of Human Genetics. 68 (1): 118—127. PMC 1234904 . PMID 11112663. doi:10.1086/316942.
Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (новембар 2005). „Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability”. Archives of Pathology & Laboratory Medicine. 129 (11): 1390—7. PMID 16253017. doi:10.5858/2005-129-1390-POTRBG.
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, et al. (фебруар 2004). „Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability”. Journal of the National Cancer Institute. 96 (4): 261—8. PMC 2933058 . PMID 14970275. doi:10.1093/jnci/djh034.
Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, et al. (децембар 2004). „Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic”. Journal of Clinical Oncology. 22 (24): 4934—43. PMID 15611508. doi:10.1200/JCO.2004.11.084. Архивирано из оригинала 2013-04-15. г.
Stjepanovic, N.; Moreira, L.; Carneiro, F.; Balaguer, F.; Cervantes, A.; Balmaña, J.; Martinelli, E.; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2019). „Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†”. Annals of Oncology. 30 (10): 1558—1571. PMID 31378807. doi:10.1093/annonc/mdz233.
Boland, C. Richard; Koi, Minoru; Chang, Dong K.; Carethers, John M. (2008). „The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: From bench to bedside”. Familial Cancer. 7 (1): 41—52. PMC 2847875 . PMID 17636426. doi:10.1007/s10689-007-9145-9. .
Le, Dung T.; et al. (2015). „PD-1 Blockade in Tumors with Mismatch-Repair Deficiency”. New England Journal of Medicine. 372 (26): 2509—2520. PMC 4481136 . PMID 26028255. doi:10.1056/NEJMoa1500596. .
André, Thierry; Shiu, Kai-Keen; Kim, Tae Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis; Smith, Denis; Garcia-Carbonero, Rocio; Benavides, Manuel; Gibbs, Peter; de la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T.; Yoshino, Takayuki; Van Cutsem, Eric; Yang, Ping; Farooqui, Mohammed Z.H.; Marinello, Patricia; Diaz, Luis A.; KEYNOTE-177 Investigators (2020). „Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer”. New England Journal of Medicine. 383 (23): 2207—2218. PMID 33264544. S2CID 227259533. doi:10.1056/NEJMoa2017699.

rarediseases.info.nih.gov

„Lynch syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program”. rarediseases.info.nih.gov. Архивирано из оригинала 16. 7. 2019. г. Приступљено 4. 10. 2019.

semanticscholar.org

api.semanticscholar.org

Bellizzi AM, Frankel WL (новембар 2009). „Colorectal cancer due to deficiency in DNA mismatch repair function: a review”. Advances in Anatomic Pathology. 16 (6): 405—17. PMID 19851131. S2CID 25600795. doi:10.1097/PAP.0b013e3181bb6bdc.
André, Thierry; Shiu, Kai-Keen; Kim, Tae Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis; Smith, Denis; Garcia-Carbonero, Rocio; Benavides, Manuel; Gibbs, Peter; de la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T.; Yoshino, Takayuki; Van Cutsem, Eric; Yang, Ping; Farooqui, Mohammed Z.H.; Marinello, Patricia; Diaz, Luis A.; KEYNOTE-177 Investigators (2020). „Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer”. New England Journal of Medicine. 383 (23): 2207—2218. PMID 33264544. S2CID 227259533. doi:10.1056/NEJMoa2017699.

web.archive.org

„Lynch syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program”. rarediseases.info.nih.gov. Архивирано из оригинала 16. 7. 2019. г. Приступљено 4. 10. 2019.
„Протеини за поправку неусклађености (ММР) - Патолошки речник - МиПатхологиРепорт.ца”. MyPathologyReport.ca (на језику: српски). Архивирано из оригинала 21. 01. 2023. г. Приступљено 2023-01-21.